Type 1 Diabetes Trial, Recruiting NCT06984185 Sponsor: Hospices Civils de Lyon Condition: Type 1 Diabetes
Back to Type 1 Diabetes

Type 1 Diabetes Trial, Recruiting

NCT06984185
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children who are older than 1 year and younger than 18 years old
  • Children with a Body Mass Index (a measure of body weight relative to height) below 30.0 kg/m²
  • Children who have been diagnosed with stage 3 type 1 diabetes, confirmed through clinical assessment, blood tests, high acid levels in the blood, and elevated ketone levels
  • The child has given their agreement to participate, and their parents or guardians do not object

Who may not be able to join:

  • Children who have type 2 diabetes or a form of diabetes that runs in the family due to a known genetic cause
  • Children who have cystic fibrosis
  • Children with a history of liver disease, kidney disease, or inflammation of the pancreas (pancreatitis)
  • Children who have any other ongoing or worsening serious illness (aside from type 2 diabetes)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0472129525

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
5 November 2025
Est. completion
5 December 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Concordance rate between the autoantibodies combined assay and the individual assays

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov